Lung Cancer: Alert 30 April-07 May

[ScienceDirect Message Center]

Can't see this email properly? Click here to view an online version

Alert: Lung Cancer

New articles available on ScienceDirect

Lung Cancer Volume 120, Pages 1-152, June 2018 Editorial Board    Page iii Contents    Pages v-vi   Reviews Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting    Review Article Pages 62-69 Martin Reck, Marina Chiara Garassino, Martina Imbimbo, Frances A. Shepherd, Mark A. Socinski, Jin-Yuan Shih, Anne Tsao, Pablo Lee, Katherine B. Winfree, Andreas Sashegyi, Rebecca Cheng, Rocio Varea, Benjamin Levy, Edward Garon   Original Research Articles Frequency and distribution of incidental findings deemed appropriate for S modifier designation on low-dose CT in a lung cancer screening program    Original Research Article Pages 1-6 Michael J. Reiter, Allison Nemesure, Ezemonye Madu, Lisa Reagan, April Plank Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis    Original Research Article Pages 7-13 Vivek Verma, Christopher A. Ahern, Christopher G. Berlind, William D. Lindsay, Surbhi Grover, Melissa J. Culligan, Joseph S. Friedberg, Charles B. Simone Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III    Original Research Article Pages 14-21 Naoki Yanagawa, Satoshi Shiono, Makoto Endo, Shin-ya Ogata Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysis    Original Research Article Pages 22-26 Lin Yang, Shidan Wang, David E. Gerber, Yunyun Zhou, Feng Xu, Jiewei Liu, Hao Liang, Guanghua Xiao, Qinghua Zhou, Adi Gazdar, Yang Xie A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)    Original Research Article Pages 27-33 Martin Forster, Allan Hackshaw, Tommaso De Pas, Manuel Cobo, Pilar Garrido, Yvonne Summers, Anne-Marie C. Dingemans, Michael Flynn, David Schnell, Ute von Wangenheim, Arsene-Bienvenu Loembé, Rolf Kaiser, Siow Ming Lee Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma    Original Research Article Pages 34-45 Joanna Kopecka, Iris C. Salaroglio, Luisella Righi, Roberta Libener, Sara Orecchia, Federica Grosso, Vladan Milosevic, Preeta Ananthanarayanan, Luisa Ricci, Enrica Capelletto, Monica Pradotto, Francesca Napoli, Massimo Di Maio, Silvia Novello, Menachem Rubinstein, Giorgio V. Scagliotti, Chiara Riganti The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)    Original Research Article Pages 46-53 Thomas Muley, Vinzent Rolny, Ying He, Birgit Wehnl, Achim Escherich, Arne Warth, Christa Stolp, Marc A. Schneider, Hendrik Dienemann, Michael Meister, Felix J. Herth, Farshid Dayyani Association between radiation heart dosimetric parameters, myocardial infarct and overall survival in stage 3 non-small cell lung cancer treated with definitive thoracic radiotherapy    Original Research Article Pages 54-59 Chia Ching Lee, Huili Zheng, Yu Yang Soon, Ling Li Foo, Wee Yao Koh, Cheng Nang Leong, Balamurugan Vellayappan, Jeremy Chee Seong Tey, Ivan Weng Keong Tham Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden    Original Research Article Pages 75-81 Salomon Tendler, Vitali Grozman, Rolf Lewensohn, Georgios Tsakonas, Kristina Viktorsson, Luigi De Petris EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism    Original Research Article Pages 82-87 Sangtian Liu, Yayi He, Tao Jiang, Shengxiang Ren, Fei Zhou, Chao Zhao, Xuefei Li, Jie Zhang, Chunxia Su, Xiaoxia Chen, Weijing Cai, Guanghui Gao, Wei Li, Fengying Wu, Jiayu Li, Jing Zhao, Qiong Hu, Mingchuan Zhao, Caicun Zhou, Fred R. Hirsch Cost-effectiveness analysis of policy options on first-line treatments for advanced, non-small cell lung cancer in Thailand    Original Research Article Pages 91-97 Chulaporn Limwattananon, Supon Limwattananon, Onanong Waleekhachonloet, Thananan Rattanachotphanit Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer    Original Research Article Pages 98-107 Shinichi Kimura, Taishi Harada, Kayo Ijichi, Kentaro Tanaka, Renpeng Liu, Daisuke Shibahara, Yuko Kawano, Kohei Otsubo, Yasuto Yoneshima, Eiji Iwama, Yoichi Nakanishi, Isamu Okamoto Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance    Original Research Article Pages 113-121 Meijun Du, Jonathan Thompson, Hannah Fisher, Peng Zhang, Chiang-Ching Huang, Liang Wang Risk factors for pulmonary nodules in north China: A prospective cohort study    Original Research Article Pages 122-129 Yu-Tong He, Ya-Chen Zhang, Gao-Feng Shi, Qi Wang, Qian Xu, Di Liang, Yu Du, Dao-Juan Li, Jing Jin, Bao-En Shan Added prognostic value of CT characteristics and IASLC/ATS/ERS histologic subtype in surgically resected lung adenocarcinomas    Original Research Article Pages 130-136 Young Joo Suh, Hyun-Ju Lee, Young Tae Kim, Chang Hyun Kang, In Kyu Park, Yoon Kyung Jeon, Doo Hyun Chung Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials    Original Research Article Pages 137-141 Hossein Maymani, Kenneth Hess, Roman Groisberg, David S. Hong, Aung Naing, Sarina Piha-Paul, Filip Janku, Siqing Fu, Apostolia M. Tsimberidou, Shubham Pant, Daniel Karp, Shuang Liu, Ming Sun, John Heymach, George Simon, Funda Meric-Bernstam, Vivek Subbiah Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy    Original Research Article Pages 142-148 Penelope A. Bradbury, Donald G. Morris, Garth Nicholas, Dongsheng Tu, Moustapha Tehfe, John R. Goffin, Frances A. Shepherd, Richard W. Gregg, Jeffrey Rothenstein, Christoper Lee, Sara Kuruvilla, Bruce D. Keith, Vamsee Torri, Normand Blais, Desiree Hao, Grzegorz J. Korpanty, Glenwood Goss, Barbara L. Melosky, Mihaela Mates, Natasha Leighl, et al.   Short Communications Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer    Pages 88-90 Tyler P. Robin, Bernard L. Jones, Arya Amini, Matthew Koshy, Laurie E. Gaspar, Arthur K. Liu, Sameer K. Nath, Brian D. Kavanagh, D. Ross Camidge, Chad G. Rusthoven PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab    Pages 108-112 Nicolas Guibert, Myriam Delaunay, Amélie Lusque, Nadia Boubekeur, Isabelle Rouquette, Estelle Clermont, Jean Mourlanette, Sandrine Gouin, Inge Dormoy, Gilles Favre, Julien Mazieres, Anne Pradines   Case Reports Lorlatinib – Induced pulmonary arterial hypertension    Pages 60-61 Alexandre Chabrol, Marie Mayenga, Abdul Momen Hamid, Sylvie Friard, Hélène Salvator, Hélèe Doubre, Séverine Fraboulet, Anne-Cécile Metivier, Emilie Catherinot, Elisabeth Rivaud, Marie Camille Chaumais, David Montani, Louis Jean Couderc, Colas Tcherakian Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations    Pages 70-74 Biagio Ricciuti, Sara Baglivo, Vienna Ludovini, Angelo Sidoni, Giulio Metro, Marta Brambilla, Annamaria Siggillino, Maria Sole Reda, Alberto Rebonato, Daniele Maiettini, Rita Chiari   Correspondence Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy    Pages 149-151 Chih-Chieh Yen, Hui-Chen Su, Chang-Yao Chu, Shi-Jie Lai, Jing-Jou Yan, Wen-Pin Su, Wu-Chou Su

Read the full issue on ScienceDirect

Access the ScienceDirect Info site if you have questions about this message or other features of this service.

This email has been sent to you by ScienceDirect, a division of Elsevier B.V., Radarweg 29, 1043 NX Amsterdam, The Netherlands, Tel.+31 20 485 3911. ScienceDirect respects your privacy and does not disclose, rent or sell your personal information to any non-affiliated third parties without your consent, except as may be stated in the ScienceDirect online privacy policy. By using email or alert services, you agree to comply with the ScienceDirect Terms and Conditions. To unsubscribe from this alert, please click here. Copyright © 2018 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V. Subscription ID: 6f791755-0730-4e1c-a43b-ccd9ee73d8c4 Webuser ID: 7366039 Results Event ID: 4e4af459-f54a-4497-b06c-1862516f6e33 Batch ID: 7bedc070-dd7c-4cad-9a55-8dd9fb006308 RTEventId: 72057594319228346